Effect of lavender in treatment of polycystic ovary syndrome

Phase 2

Recruiting

• Conditions: Polycystic ovary syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20210915052488N1
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 68

Inclusion Criteria

Diagnosis of polycystic ovary syndrome by a gynecologist

Exclusion Criteria

Do not take drugs that lower blood pressure, blood fats and blood sugar
No pregnancy or breastfeeding
Do not take insulin sensitizers
Do not take aspirin or other anticoagulants
Do not take anti-prostaglandin drugs
Do not take other herbal medicines at the same time for your disease
No history of uncontrolled blood pressure, stroke, heart attack, cancer or heart attack, cardiovascular disease, liver, kidney and thyroid disorders, type 1 or 2 diabetes
No smoking
Do not take oral contraceptives

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Check menstrual days. Timepoint: After three months of treatment in the luteal phase. Method of measurement: Day.

Secondary Outcome Measures

Name	Time	Method
Measurement of serum Progesterone in the luteal phase. Timepoint: After three months of treatment in the luteal phase. Method of measurement: Measurement of serum progesterone in the luteal phase more than 3 Nanogram / milliliter.